PCV7

BIOLOGICAL2 trials

Sponsors

UMC Utrecht, Novartis Vaccines

Conditions

Meningococcal MeningitisStreptococcus Pneumoniae Infection

Phase 3

Effect of Two Versus Three Pneumococcal Conjugate Vaccinations

CompletedNCT00189020

UMC UtrechtStreptococcus Pneumoniae Infection

Start: 2005-06-30Updated: 2011-08-22

Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers

CompletedNCT00667602

Novartis VaccinesMeningococcal Meningitis

Start: 2008-03-31End: 2010-10-31Updated: 2013-11-07

Related Papers

Bactericidal antibodies against hypervirulent <i>Neisseria meningitidis</i> C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children

Human Vaccines & Immunotherapeutics2020-12-161 citations

Early Respiratory Microbiota Composition Determines Bacterial Succession Patterns and Respiratory Health in Children

American Journal of Respiratory and Critical Care Medicine2014-10-20564 citations

Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose

Vaccine2013-10-106 citations

Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial.

2011-06-1074 citations

Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains.

2010-09-0149 citations

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.

2009-07-01121 citations